Rank 48 • AI & Clinical Intelligence
Cleerly
Utilizes artificial intelligence to analyze coronary CT angiograms, providing detailed evaluations of cardiovascular disease and plaque.
Visit website- Signal Score
- 87.1
- Total raised
- $248M
- Stage
- Series C
- Founded
- 2017
- Headquarters
- Denver, USA
- Region
- North America
Their signal
Cleerly is redefining cardiovascular diagnostics, leveraging deep clinical validation and high-profile funding to establish AI-based personalized heart disease tracking as a clinical standard.
Signal Score 87.1editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Did we miss something?
Change, add or remove details on this company. Our desk reviews every request.
Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.